As of Jul 20
| +0.07 / +0.29%|
The 8 analysts offering 12-month price forecasts for NxStage Medical Inc have a median target of 31.00, with a high estimate of 33.00 and a low estimate of 27.00. The median estimate represents a +27.36% increase from the last price of 24.34.
The current consensus among 9 polled investment analysts is to Buy stock in NxStage Medical Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.